BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 7784081)

  • 1. Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.
    Lieu C; Heymach J; Overman M; Tran H; Kopetz S
    Clin Cancer Res; 2011 Oct; 17(19):6130-9. PubMed ID: 21953501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition.
    Bachleitner-Hofmann T; Sun MY; Chen CT; Liska D; Zeng Z; Viale A; Olshen AB; Mittlboeck M; Christensen JG; Rosen N; Solit DB; Weiser MR
    Clin Cancer Res; 2011 Jan; 17(1):122-33. PubMed ID: 21208906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency trans-splicing in a cell line producing spliced and polyadenylated RNA polymerase I transcripts from an rDNA-myc chimeric gene.
    Chen C; Fossar N; Weil D; Guillaud-Bataille M; Danglot G; Raynal B; Dautry F; Bernheim A; Brison O
    Nucleic Acids Res; 2005; 33(7):2332-42. PubMed ID: 15849319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of adenoviral E1A protein to analyze K18 promoter deregulation in colon carcinoma cells discloses a role for CtBP1 and BRCA1.
    Delouis C; Prochasson P; Laithier M; Brison O
    BMC Mol Biol; 2005 Apr; 6():8. PubMed ID: 15831101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional deregulation of the keratin 18 gene in human colon carcinoma cells results from an altered acetylation mechanism.
    Prochasson P; Delouis C; Brison O
    Nucleic Acids Res; 2002 Aug; 30(15):3312-22. PubMed ID: 12140315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic consequences of lung-specific inducible expression of FGF-3.
    Zhao B; Chua SS; Burcin MM; Reynolds SD; Stripp BR; Edwards RA; Finegold MJ; Tsai SY; DeMayo FJ
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5898-903. PubMed ID: 11331772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the murine k-fgf gene.
    Rizzino A; Rosfjord E
    Mol Reprod Dev; 1994 Sep; 39(1):106-11. PubMed ID: 7999355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
    Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
    Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
    Donzelli M; Bernardi R; Negri C; Prosperi E; Padovan L; Lavialle C; Brison O; Scovassi AI
    Oncogene; 1999 Jan; 18(2):439-48. PubMed ID: 9927200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
    Ray R; Thomas S; Miller DM
    Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line.
    Galdemard C; Brison O; Lavialle C
    Oncogene; 1995 Jun; 10(12):2331-42. PubMed ID: 7784081
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.